+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2024 Competing in the Global Immunohematology and NAT Testing Market: Supplier Shares, Segment Forecasts, Latest Trends, Growth Opportunities

  • PDF Icon

    Report

  • 775 Pages
  • September 2020
  • Region: Global
  • VPG Market Research
  • ID: 4852829

This new 775-page seven-country study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report is available by section, and can be customized to specific information needs and budget.

Rationale

During the next five years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

The report explores future marketing and technological trends in the US, Europe and Japan; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Sales and Market Share Analysis

Sales and market share estimates for leading
suppliers of transfusion diagnostic testing reagents
and instruments, by country and individual
product.

Instrument Placements

Annual placements and installed base of
major automated and semi-automated
analyzers, by supplier and model.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.

- Test volume and sales forecasts for over 40
transfusion diagnostic tests, including NAT,
by country and market segment:

- Blood Centers
- Plasma Fractionation Facilities
- Hospitals
- Commercial/Private Laboratories
- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging transfusion
diagnostic tests.

- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging
technologies, and their potential applications
for the transfusion diagnostics market.

- Comprehensive lists of companies developing
or marketing new technologies and products, by test.

Worldwide Market Overview

- Estimates of facilities performing transfusion diagnostic
tests, by country.

- Test volume and sales projections by country.

Strategic Recommendations

- New product development
opportunities with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

The report is based on combination of primary and secondary information sources, including interviews with blood bankers, laboratory directors, and executives of leading diagnostics companies in the U.S., five major European countries, and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as ’s proprietary data files was conducted.

Contains 775 pages and 227 tables


Companies Mentioned

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Quest Diagnostics
  • Quidel
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher